Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy Grant

Overview

date/time interval

September 30, 2018 - September 29, 2022

awarded by

United States Department of Defense

administered by

missing organization

sponsor award ID

W81XWH-18-1-0528